EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib (Q35841043)
Jump to navigation
Jump to search
scientific article published on 16 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib |
scientific article published on 16 January 2012 |
Statements
1 reference
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib (English)
1 reference
Keith T Flaherty
1 reference
Dora Dias-Santagata
1 reference
Jeffrey A Engelman
1 reference
Ryan B Corcoran
1 reference
Jeffrey Settleman
1 reference
Jennifer A Wargo
1 reference
Adriano Piris
1 reference
Hiromichi Ebi
1 reference
Alexa B Turke
1 reference
Erin M Coffee
1 reference
Michiya Nishino
1 reference
Alexandria P Cogdill
1 reference
Ronald D Brown
1 reference
Patricia Della Pelle
1 reference
Kenneth E Hung
1 reference
16 January 2012
1 reference
1 reference
227-235
1 reference
Identifiers
1 reference
1 reference
1 reference